Biotech

All Articles

Praxis epilepsy medicine reduces seizures in stage 2 trial

.Practice Accuracy Medicines has scored one more midphase succeed in epilepsy this year, with its ow...

Three directors surrender as Dyne blog posts blended data for DMD prospect

.After getting away a medical grip a number of years back, Dyne Therapy has exposed new stage 1/2 in...

Arrowhead fires off phase 3 information in uncommon metabolic ailment ahead of market clash with Ionis

.Arrowhead Pharmaceuticals has actually presented its own give in advance of a possible showdown alo...

Pfizer, Valneva show lyme health condition chance reliable for second booster

.Pfizer as well as Valneva might have about pair of more years to wait just before they help make th...

Fierce Biotech Managing Editor Ayla Ellison Chats Shop with Michelle Benz on the Future of Biotech.

.Permit's dive into a chat with Ayla Ellison, Intense Biotech Managing Editor and Michelle Benz as t...

New data demonstrate how Bayer's asundexian fell short to prevent movements

.Bayer put on hold the period 3 test for its own aspect XIa prevention asundexian late last year aft...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS trials

.Sanofi is actually still bented on taking its own numerous sclerosis (MS) med tolebrutinib to the F...

Galapagos' stock up as fund presents intent to form its own advancement

.Galapagos is actually coming under extra stress from investors. Having built a 9.9% risk in Galapag...

Cell- focused Sana scoops initial CSO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of notable leadership hirings, firings as well a...

Allist pays Jacobio $21M, landing duty in Chinese KRAS race

.Shanghai Allist Pharmaceuticals has acquired itself a starring character in China's KRAS market, sp...